Stock daily read

What happened with TRUP today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

TRUP in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Trupanion helps pet owners cover veterinary treatment costs in the United States, Canada and parts of continental Europe. Most revenue comes from its subscription business, primarily insurance premiums paid by pet owners. It sets premiums according to each pet’s characteristics and chosen coverage, and pays covered veterinary bills. At hospitals using its direct-payment software, Trupanion can pay approved bills directly, leaving owners to pay only their deductible or co-payment for covered treatment. Veterinary referrals are its largest source of new members.

Trupanion also earns a substantial share of revenue by underwriting insurance sold by other companies. This business depends heavily on Pets Best and has much lower margins than the subscription business. Pets Best is moving policies to other insurers, and Trupanion expects that relationship to shrink and eventually end.

The core business depends on attracting and retaining pet owners while setting premiums that cover veterinary bills and operating costs. Most U.S. states require regulatory approval before Trupanion introduces products or raises prices, which can limit how quickly premiums adjust to costs. Its insurance subsidiaries must also retain required capital, restricting the funds available for growth and general operations.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in TRUP’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

TRUP says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

Trupanion’s results hinge on subscription enrollment and premiums keeping pace with veterinary bills, while Pets Best’s move to other underwriters shrinks Trupanion’s lower-margin third-party business.

  • Lemonade competes with Trupanion for pet owners’ insurance premiums, and both pay claims for veterinary care. Watch Lemonade’s pet-insurance enrollment and claims costs for signs of competition for customers and pressure from veterinary bills.

Agenda

in 8 daysWed, Oct 28

  1. 2:00 PMET

    Fed Interest Rate Decision

    The Fed’s decision on its benchmark interest rate matters to Trupanion because higher rates can raise interest costs on its SOFR-linked loans, leaving less cash for operations and growth.

in 15 daysWed, Nov 4

  1. Time to be announced

    Lemonade, Inc. earningsLMND

    Lemonade’s report will show how pet-insurance enrollment and veterinary claims costs are changing in the market where it competes with Trupanion for customers and pays the same kind of bills.

in 16 daysThu, Nov 5

  1. Time to be announced
    Major

    Trupanion, Inc. earningsThis company

    Trupanion’s report will show whether its pet-insurance subscriptions bring in enough revenue from enrolled pets to cover veterinary claims and the cost of acquiring new members.